Skip to main content

Wrongful Death Claim Linked to J&J’s Talcum Powder

Wrongful Death Claim Linked to J&J’s Talcum Powder

Wrongful Death Claim Linked to J&J’s Talcum Powder

Introduction

A man filed a wrongful death lawsuit in the U.S. District Court for the Western District of Louisiana claiming his mother developed ovarian cancer following the use Johnson & Johnson’s Talcum Baby Powder and Shower-to-Shower product for feminine hygiene purposes, which finally resulted in her death. The man states his mother used the Talcum powder for over 25 years. Allegations include that J&J, Imerys Talc, and other defendants had the knowledge of the increased risk of ovarian cancer associated with the genital use of the talc-based body powder, yet they continued to actively market the safety of the product to users and failed to inform about their associated health hazards.

The defendants maintain their products did not cause any harm and show no intention of offering any settlements for ovarian cancer lawsuits. They face nearly 7,000 Talcum Powder lawsuits nationwide.

Talcum ovarian cancer lawsuits were centralized in 2016, as a part of MDL No. 2738- in re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation, presided by Hon. Freda L. Wolfson, U.S.D.J. / Hon. Lois H. Goodman, U.S.M.J., in the U.S. District Court for the District of New Jersey; hundreds of similar lawsuits are filed in Missouri 22nd Circuit Court, St. Louis, including California and Delaware state courts.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Attorneys Seek Reconsideration of Talc MDL Daubert Ruling

Categories: General

Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…

Philips resolves DreamStation suits for $1.1B

Categories: Settlements

Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…

FDA OKs Generic OTC Naloxone Spray Approved by FDA

Categories: FDA Related

The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.

Our Legal Drafting Services    
start @ $25 per hour.